Sustaining Diabetes Shared Medical Appointments After a Pragmatic Trial
Andrea L Nederveld1, Dennis Gurfinkel2, Julia Reedy2
1From the Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO (ALN, REG, JAW, JSH); Adult and Child Center for Outcomes Research and Delivery Science, Children's Hospital Colorado and University of Colorado Anschutz Medical Campus, Aurora, CO (DG, JR, REG. JAW, BMK, JSH); Department of Emergency Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO (BMK). andrea.nederveld@cuanschutz.edu.
Purpose:
The purpose of this study is to gain understanding on factors identified by primary care practice members as impacting sustainability of diabetes Shared Medical Appointments (SMAs) after participating in a pragmatic trial that included sustainability planning. SMAs provide diabetes self-management education and support (DSMES) in primary care, though sustainability can be challenging.
Methods:
The Invested in Diabetes study was a pragmatic comparative effectiveness trial of 2 approaches to providing SMAs for adults with type 2 diabetes. Qualitative interviews at the study end explored primary care practices' experiences with SMAs and perspectives on sustainability, analyzed using a grounded theory hermeneutic editing approach.
Results:
Seventy-nine interviews were conducted in 20 participating practices. One primary finding and 3 themes on factors necessary for sustainment emerged: finding: SMAs were seen as valuable, but sustainment plans were inconsistent; theme 1) Sustainability hinges on practical factors, some not supported in current health care payment models; theme 2) Relevance and efficiency are important: future diabetes SMAs anticipated adaptations or revisions; and theme 3) Improvement in reportable practice quality measures would be an incentive to continue SMAs.
Discussion:
Diabetes SMAs were perceived as beneficial, but difficult to sustain. We found that primary care teams want to provide SMAs and that changes in how primary care practices are reimbursed could support implementation and sustainment of DSMES approaches such as SMAs, leading to improved patient outcomes.
Conclusion:
There is urgent need for explicit attention to policy change, health care payment innovation, and novel reimbursement models to enhance sustainability of diabetes SMAs.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...


